Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Annals of Surgical Oncology|May 21, 2014
A competing risk analysis of cancer-specific mortality of initial treatment with radical prostatectomy versus radiation therapy in clinically localized high-risk prostate cancerJoo Yong Lee, Kang Su Cho, Jong Kyou Kwon, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patientsHo Won Kang, Phil Hyun Song, Yun-Sok Ha, et al.
Oncology Reports|November 18, 2015
RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancerHyung-Yoon Yoon, Yong-June Kim, Ji Sang Kim, et al.
Journal of Korean Medical Science|December 17, 2013
Diagnostic role of prostate resection in the elderly patients who experience significant co-morbidity with a high clinical suspicion of prostate cancerHo Won Kang, Jin Bak Yang, Whi-An Kwon, et al.
The Journal of Urology|July 27, 2017
Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic AlopeciaHo Won Kang, Myeong Heon Chae, Su Hyun Park, et al.
Prostate International|February 14, 2022
Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancerYoung Joon Byun, Ho Won Kang, Xuan-Mei Piao, et al.
Oncology Letters|November 8, 2024
Single‑center, retrospective, evaluator‑blinded, pilot and pivotal clinical trials: Assessing the mirCaP Kit (hsv2‑miR‑H9/hsa‑miR‑3659) as a diagnostic marker for prostate cancer in patients with PSA levels in the gray zoneWon Tae Kim, Kyeong Kim, Ho Won Kang, et al.
Investigative and Clinical Urology|July 16, 2020
A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zoneHo Won Kang, Hee Youn Lee, Young Joon Byun, et al.
International Journal of Cancer|February 26, 2013
HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profilingYong-June Kim, Hyung-Yoon Yoon, Ji Sang Kim, et al.
Annals of Surgical Oncology|February 25, 2014
DHCR24 is an independent predictor of progression in patients with non-muscle-invasive urothelial carcinoma, and its functional role is involved in the aggressive properties of urothelial carcinoma cellsGeun Taek Lee, Yun-Sok Ha, Yeon Suk Jung, et al.
Pageof 15